Maraviroc
- Product NDC
- 72319-025
- 11-digit product format
- 723190025
- Labeler code
- 72319
- Product ID
- 72319-025_0416607a-fd74-87e3-e063-6294a90ae6b5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Maraviroc
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- i3 Pharmaceuticals, LLC
- Application
- ANDA217114
- Marketing category
- ANDA
- Marketing start
- 2023-09-15
- Substance
- MARAVIROC
- Active strength
- 300 mg/1
- Pharmacologic classes
- CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Maraviroc
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MARAVIROC | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | MD6P741W8A |
| Rxcui | 728223, 728225 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72319-025-02 | Maraviroc | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72319-025 | MARAVIROC TABLET, FILM COATED [I3 PHARMACEUTICALS, LLC] | 3 | Current NDC, 1 package rows | 20230915_f7b9c67b-10c6-45b5-b2a8-952cd350b0b1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 72319-025-02 | 72319002502 | 60 TABLET, FILM COATED in 1 BOTTLE (72319-025-02) | 2023-09-15 | No | No | Historical |